Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraoperative methylene blue infusion for prevention of postoperative depression after laparoscopic total hysterectomy
ChiCTR2600122409Phase 4Not yet recruiting
- Sponsor
- Chengdu Qingbaijiang District People's Hospital
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in major depressive disorder (MDD) comparing Methylene blue group with Control group (placebo dextrose infusion) (2 arms). Primary endpoint: Hamilton Depression Scale score. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
methylene blue
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on ChiCTR2600122409.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600122409.